Overcoming Endocrine Resistance in Breast Cancer.

Hanker, Ariella B; Sudhan, Dhivya R; Arteaga, Carlos L

Hanker, Ariella B; Sudhan, Dhivya R; Arteaga, Carlos L.

Afiliação

Hanker AB; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: ariella.hanker@utsouthwestern.edu.
Sudhan DR; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Arteaga CL; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: carlos.arteaga@utsouthwestern.edu.

Cancer Cell ; 37(4): 496-513, 2020 04 13.

Article em En | MEDLINE | ID: mdl-32289273

Assuntos

Antineoplásicos Hormonais/farmacologia; Neoplasias da Mama/tratamento farmacológico; Resistencia a Medicamentos Antineoplásicos; Receptores de Estrogênio/metabolismo; Neoplasias da Mama/metabolismo; Neoplasias da Mama/patologia; Gerenciamento Clínico; Feminino; Humanos; Microambiente Tumoral

Palavras-chave

ESR1; SERD; SERM; aromatase inhibitor; breast cancer; endocrine resistance; estrogen receptor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Estrogênio / Resistencia a Medicamentos Antineoplásicos / Antineoplásicos Hormonais Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google